Melatonin In Reduction of Chemotherapy-Induced Toxicity (MIRCIT) Trial

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

June 30, 2012

Conditions
Advanced Stage Cancer
Interventions
DRUG

10 mg Melatonin

Active Comparator: Drug: Melatonin 10 mg

DRUG

20 mg Melatonin

Active Comparator: Drug: Melatonin 20 mg

DRUG

Matched placebo

Matched placebo (identical formulation and delivery, without active ingredient)

Trial Locations (2)

40000

Khon Kaen Hospital, Khon Kaen

40002

Srinagarind Hospital, Khon Kaen

All Listed Sponsors
collaborator

Srinagarind Hospital, Khon Kaen University

OTHER

collaborator

Khon Kaen Hospital, Khon Kaen

UNKNOWN

collaborator

General Drugs House Co.,LTD.

OTHER

collaborator

Thailand Research Fund

OTHER

lead

Khon Kaen University

OTHER

NCT01706627 - Melatonin In Reduction of Chemotherapy-Induced Toxicity (MIRCIT) Trial | Biotech Hunter | Biotech Hunter